Your browser doesn't support javascript.
loading
Pinloc or Hansson pins: a multicenter, randomized controlled study of 439 patients treated for femoral neck fractures.
Åberg, Henrik; Kalland, Kristine; Jonsson, Kenneth B; Johansson, Torsten.
Affiliation
  • Åberg H; Department of Orthopedic Surgery, Institution of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Kalland K; Department of Orthopedic Surgery, Nyköping Hospital, Nyköping, Sweden.
  • Jonsson KB; Department of Orthopedic Surgery, Institution of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Johansson T; Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
OTA Int ; 6(4): e282, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37744995
ABSTRACT

Objectives:

To compare the recently developed Hansson Pinloc system, which features 3 cylindrical parallel pins with hooks connected through a fixed-angle interlocking plate, with the Hansson Pin System (2 hook pins) for the treatment of femoral neck fractures.

Design:

One hundred fourteen patients with displaced femoral neck fractures and 325 patients with nondisplaced fractures from 9 orthopaedic centers were randomized to either Hansson Pinloc system or Hansson Pin System and followed for 2 years or until death. Age at inclusion was 50 years or older. Main Outcome Measurements The primary outcome was failure (defined as early displacement, nonunion, symptomatic avascular necrosis, or deep infection). Secondary outcomes included revision surgery, Timed Up and Go (TUG) test and patient-reported outcome measures (PROMs EQ-5D and WOMAC).

Results:

For nondisplaced fractures, the incidence of failure was 14% (23/169) in the Pinloc group and 16% (25/156) in the Hansson group. For displaced fractures, the analysis was stratified by age. Patients aged 50-69 years with displaced fractures showed a 2-year failure rate of 44% (17/39) in the Pinloc group versus 44% (16/36) in the Hansson group. For patients 70 years or older with displaced fractures, 33% (7/21) in the Pinloc group versus 22% (4/18) in the Hansson group failed. At 3 and 12 months, no clinically significant differences between treatment groups were found for EQ-5D-3L, WOMAC, or for the TUG in any fracture type or age group.

Conclusions:

There were no advantages for Pinloc in any of the studies aspects. Level of evidence 1.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Aspects: Patient_preference Language: En Journal: OTA Int Year: 2023 Document type: Article Affiliation country: Suecia Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Aspects: Patient_preference Language: En Journal: OTA Int Year: 2023 Document type: Article Affiliation country: Suecia Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA